Quarterly report pursuant to Section 13 or 15(d)

4. Commitments and Contingencies (Details Narrative)

v2.4.0.6
4. Commitments and Contingencies (Details Narrative) (USD $)
3 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Feb. 14, 2011
Commitments And Contingencies Details Narrative      
Potential severance $ 1,918,000    
Aggregated annual salaries 1,360,000    
One-time non-refundable option payment from AmDerma     500,000
Revenue related to Vetericyn and Microcyn over-the-counter sales 1,136,000 563,000  
Outstanding accounts receivable related to Vetericyn and Microcyn over-the-counter sales $ 837,000 $ 290,000